跳至主要内容
临床试验/KCT0005313
KCT0005313已完成未知

Human application test to evaluate blood sugar improvement and health promotion effect by participating in lifestyle improvement program in diabetics

Chonbuk National University Hospital0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • (1) Male and female adults aged 19 or older at the time of the screening test
  • (2) Diabetes diagnosed at the time of screening (6.5%= HbA1c < 9.0%)
  • (3) Those who have heard and fully understood the detailed description of this human study and have agreed in writing to decide his/her own participation and to comply with the precautions

排除标准

  • (1) Patients with type 1 diabetes and type 2 diabetes who have had or are administering insulin medications within the last 3 months.
  • (2) Patients with clinically significant acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, hepatobiliary system, kidney and urinary system, neuropsychiatric system, musculoskeletal system, inflammatory and blood and tumor diseases.
  • (3) Patients with a history of gastrointestinal diseases (such as Crohn's disease) or gastrointestinal surgery (except simple appendectomy or hernia surgery) that can affect the absorption of nutrients
  • (4) Those who are unable to participate in the lifestyle intervention program (LSI), such as dietary intake and exercise prescriptions according to dietary prescriptions
  • (5) Those who continue to take anti-psychotic drugs or narcotic analgesics within six months prior to the screening test
  • (6) Those suspected of alcoholism or drug abuse or who has a history
  • (7) Those who showed the following results in a diagnostic examination
  • ? Serum AST, ALT > three times the upper limit of the reference range
  • ? Serum creatinine > 2.0mg/dL
  • (8) Those who participated in another human study within two months before the screening test
  • (9) Screening tests show that pregnant women, breast feeding women, and possibly pregnant patients (if the menstrual period lasts at least 12 months, it shall be regarded as menopause, and if contraceptive method are used using hormone preparations, such as oral contraceptives, they shall be used at the same time from the screening test) do not use appropriate contraception methods (e.g., hormone transplants, intrauterine devices, oral contraceptives, etc.)

研究者

相似试验

Human application test to evaluate blood sugar... | 临床试验